4-methoxy-N-(2-methylquinolin-8-yl)-2-nitrobenzenesulfonamide

ID: ALA271233

PubChem CID: 23631949

Max Phase: Preclinical

Molecular Formula: C17H15N3O5S

Molecular Weight: 373.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(S(=O)(=O)Nc2cccc3ccc(C)nc23)c([N+](=O)[O-])c1

Standard InChI:  InChI=1S/C17H15N3O5S/c1-11-6-7-12-4-3-5-14(17(12)18-11)19-26(23,24)16-9-8-13(25-2)10-15(16)20(21)22/h3-10,19H,1-2H3

Standard InChI Key:  FFFWFVRMWPALDL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   10.8207  -19.1028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8207  -19.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5323  -20.3401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5323  -18.6873    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2486  -19.1028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2451  -19.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9551  -20.3430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6731  -19.9352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9621  -18.6903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6741  -19.1102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6876  -17.4601    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   12.9657  -17.8661    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3996  -17.8799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3865  -18.7055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0909  -19.1274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8132  -18.7282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8263  -17.9026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1172  -17.4761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0896  -16.7469    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.2678  -16.7469    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.1080  -18.6936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5176  -19.1514    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.5035  -19.9731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1282  -16.6499    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4225  -16.2287    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.8458  -16.2494    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 11 12  1  0
 13 14  1  0
  1  2  1  0
  1  4  2  0
  2  3  2  0
  5  9  2  0
  6  7  2  0
  7  8  1  0
 13 18  2  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
  8 10  2  0
 11 19  2  0
  9 10  1  0
 11 20  2  0
  3  6  1  0
  1 21  1  0
  5  4  1  0
 16 22  1  0
  5  6  1  0
 22 23  1  0
  9 12  1  0
 13 11  1  0
 24 25  2  0
 24 26  1  0
 18 24  1  0
M  CHG  2  24   1  26  -1
M  END

Associated Targets(Human)

NFKBIA Tchem NF-kappaB inhibitor alpha (187 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RELA Tchem Nuclear factor NF-kappa-B p65 subunit (627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 373.39Molecular Weight (Monoisotopic): 373.0732AlogP: 3.26#Rotatable Bonds: 5
Polar Surface Area: 111.43Molecular Species: ACIDHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 5.88CX Basic pKa: 4.23CX LogP: 2.39CX LogD: 1.67
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.54Np Likeness Score: -1.93

References

1. Xie Y, Deng S, Thomas CJ, Liu Y, Zhang YQ, Rinderspacher A, Huang W, Gong G, Wyler M, Cayanis E, Aulner N, Többen U, Chung C, Pampou S, Southall N, Vidović D, Schürer S, Branden L, Davis RE, Staudt LM, Inglese J, Austin CP, Landry DW, Smith DH, Auld DS..  (2008)  Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation.,  18  (1): [PMID:18024113] [10.1016/j.bmcl.2007.10.100]
2. Tsai KC, Teng LW, Shao YM, Chen YC, Lee YC, Li M, Hsiao NW..  (2009)  The first pharmacophore model for potent NF-kappaB inhibitors.,  19  (19): [PMID:19726185] [10.1016/j.bmcl.2009.08.021]

Source